National Comprehensive Cancer Network Announces Selected Projects to Study Neratinib in Collaboration With Puma Biotechnology, Inc.

Press/Media

PeriodJul 16 2021

Media coverage

1

Media coverage

  • TitleNational Comprehensive Cancer Network Announces Selected Projects to Study Neratinib in Collaboration With Puma Biotechnology, Inc.
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date07/16/21
    PersonsNeena Vijayvergia